AMA Addresses Prior Authorization Issues

At the 2024 American Medical Association (AMA) Annual Meeting, significant steps were taken to confront the ongoing challenges surrounding prior authorization in healthcare. With a focus on enhancing patient care and reducing administrative burdens on physicians, the AMA has mandated detailed denial letters and endorsed the implementation of real-time benefit tools. These measures aim to mitigate denials and streamline the prior authorization process.

The Prior Auth Problem

Prior authorization is a complex process that physicians face regularly. It often involves a lack of information in denial letters, leading to frustration for both patients seeking treatment and physicians attempting to support them. The AMA has been advocating for physicians, aiming to eliminate care delays, patient harm, and practice hassles.

The association has been actively working to address these issues. They have secured a CMS final rule that requires government-regulated health plans to reduce the timeframes for prior authorization decisions and to publicly report program metrics. These plans are also required to offer electronic prior authorization technology that directly integrates with Electronic Health Records systems.

Ensuring Transparency in Prior Authorization Act – Detailed Denial Letters

During the meeting, the AMA House of Delegates passed a series of policies aimed at fostering collaboration between healthcare providers and payers to address the complexities associated with prior authorization denials. One notable policy involves the requirement for detailed denial letters, ensuring that healthcare professionals receive clear and comprehensive explanations when prior authorization requests are denied.

To further address the confusion arising from prior authorization denial letters, the AMA House of Delegates adopted a policy to work with payers and interested parties.

This policy is part of the “Ensuring Transparency in Prior Authorization Act”, which aims to ensure that prior authorization denial letters include a detailed explanation of the denial reason, a copy of or publicly accessible link to any plan policy or coverage rules cited or used as part of the denial, and what rationale or additional documentation the plan needs to approve the original prescription and alternative options to the denied medication.

Minimizing Insurance Denials – Real-Time Benefit Tools

In addition to advocating for improved communication between payers and providers, the AMA also threw its support behind the adoption of real-time benefit tools. These tools provide clinicians with immediate access to information regarding a patient’s insurance coverage and any associated prior authorization requirements. By integrating real-time benefit tools into electronic health record systems, physicians can make more informed decisions about treatment plans, potentially reducing the likelihood of denials.

This can reduce the number of denial letters, increase the information accessible to physicians, and allow doctors to focus on patient care instead of appeals.

What’s Next?

These efforts represent a significant step forward in addressing the challenges of prior authorization. However, there is still much work to be done. By mandating detailed denial letters and supporting real-time benefit tools, they aim to reduce denials, improve patient care, and alleviate the burdens faced by physicians. As the healthcare industry continues to evolve, efforts in this area will undoubtedly continue to be of critical importance.